• OPEN AN ACCOUNT
Indian Indices
Nifty
21,995.85 -152.05
(-0.69%)
Sensex
72,488.99 -454.69
( -0.62%)
Bank Nifty
47,069.45 -415.35
( -0.87%)
Nifty IT
33,498.65 -76.30
( -0.23%)
Global Indices
Nasdaq
15,683.37 -181.88
(-1.15%)
Dow Jones
37,753.31 -45.66
(-0.12%)
Hang Seng
16,385.87 134.03
(0.82%)
Nikkei 225
38,079.70 117.90
(0.31%)
Forex
USD-INR
83.59 0.12
(0.14%)
EUR-INR
88.79 -0.05
(-0.06%)
GBP-INR
103.96 -0.07
(-0.06%)
JPY-INR
0.54 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Vapi Enterprise Ltd
Industry :  Paper
BSE Code
ISIN Demat
Book Value()
502589
INE464D01014
148.6802632
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
21.77
24.62
EPS(TTM)
Face Value()
Div & Yield %
4.96
10
0
 

Ipca Laboratories consolidated net profit declines 41.24% in the March 2023 quarter
May 29,2023
Net profit of Ipca Laboratories declined 41.24% to Rs 76.52 crore in the quarter ended March 2023 as against Rs 130.23 crore during the previous quarter ended March 2022. Sales rose 17.26% to Rs 1511.63 crore in the quarter ended March 2023 as against Rs 1289.10 crore during the previous quarter ended March 2022.

For the full year,net profit declined 46.69% to Rs 471.32 crore in the year ended March 2023 as against Rs 884.08 crore during the previous year ended March 2022. Sales rose 7.11% to Rs 6244.32 crore in the year ended March 2023 as against Rs 5829.79 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales1511.631289.10 17 6244.325829.79 7
OPM %11.9817.01 -14.8422.46 -
PBDT198.98230.49 -14 1006.851368.14 -26
PBT129.44169.55 -24 745.291135.72 -34
NP76.52130.23 -41 471.32884.08 -47